Compound ID | 202
Class: Quinolinol derivative
Spectrum of activity: | Gram-negative |
Details of activity: | MRSA (methicillin resistant Staphylococcus aureus) |
Combined with other compounds: | Yes |
Propensity to select resistant mutants: | Yes |
Institute where first reported: | Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA |
Year first mentioned: | 2015 |
Highest developmental phase: | Preclinical |
Development status: | Active |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/2820501 |
Citations: |
|